ADAR1 Capital Management’s Checkpoint Therapeutics CKPT Stock Holding History

ADAR1 Capital Management’s Portfolio CKPT Stock Details CKPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-305,800	Closed	-$1.24M	–	215
2025 Q1	$1.24M	Buy	+305,800	New	+$1.02M	0.23%	73

ADAR1 Capital Management's CKPT Position: Q2 2025 in Review

ADAR1 Capital Management sold out of Checkpoint Therapeutics (CKPT) in Q2 2025, closing a stake of 305,800 shares — an estimated $1.24M sold.

ADAR1 Capital Management first reported a position in CKPT in Q1 2025 and held it in 1 quarter. The position peaked at $1.24M in Q1 2025. 0 funds tracked by Wall St. Rank hold CKPT as of Q2 2025.

ADAR1 Capital Management reported no remaining Checkpoint Therapeutics position as of Q2 2025 after selling out during the quarter.
ADAR1 Capital Management sold 305,800 Checkpoint Therapeutics shares in Q2 2025, an estimated $1.24M.
ADAR1 Capital Management first reported a position in Checkpoint Therapeutics in Q1 2025 and held it in 1 quarter.
ADAR1 Capital Management's Checkpoint Therapeutics position peaked at $1.24M in Q1 2025.
0 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q2 2025.

Based on ADAR1 Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.